Tuncer, Ilyas <br/><br/>
Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.  [electronic resource] 

 -  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie  Sep 2003 
 - 159-66 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0940-2993 
<br/><br/><label>Standard No.: </label>10.1078/0940-2993-00309  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--analysis<br/>Angiotensin II Type 1 Receptor Blockers<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Animals<br/>Benzimidazoles--therapeutic use<br/>Biphenyl Compounds<br/>Captopril--therapeutic use<br/>Carbon Tetrachloride--toxicity<br/>Cell Count<br/>Disease Models, Animal<br/>Immunohistochemistry<br/>Liver--chemistry<br/>Liver Cirrhosis, Experimental--drug therapy<br/>Male<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tetrazoles--therapeutic use<br/>Treatment Outcome